Brainomix is an Oxford-based company specializing in the creation of AI-enabled software solutions to enable image-guided precision medicine for better treatment decisions in healthcare. Since launching as a spin-out from the University of Oxford in 2010, it has developed award-winning, AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions. Its e-Stroke platform provides clinicians with the most comprehensive stroke imaging solution, driving faster treatment times and improving functional independence for patients.

To learn more about Brainomix and its technology visit